Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Novartis N Ord (0QLR) Share Price

Price 127.36 on 26-02-2026 at 19:40:03
Change -1.23 -0.96%
Buy 130.54
Sell 124.18
Last Trade: Unknown 80,999.00 at 128.10
Day's Volume: 371,678
Last Close: 127.36
Open: 129.16
ISIN: CH0012005267
Day's Range 125.94 - 129.33
52wk Range: 81.23 - 129.33
Market Capitalisation: -
VWAP: 128.47347
Shares in Issue: 1.91b

Novartis N Ord (0QLR) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Unknown* 80,999 128.10 OTC Trade
17:48:45 - 26-Feb-26
Unknown* 4,700 128.10 OTC Trade
17:40:43 - 26-Feb-26
Unknown* 833 129.20473 SI Trade
Negotiated Trade
17:34:17 - 26-Feb-26
Unknown* 1,235 129.40 OTC Trade
17:31:49 - 26-Feb-26
Unknown* 705 128.08078 OTC Trade
17:29:24 - 26-Feb-26
Unknown* 1,890 128.08078 OTC Trade
17:29:24 - 26-Feb-26
Unknown* 40 128.08075 OTC Trade
17:29:24 - 26-Feb-26
Unknown* 3,000 129.06 OTC Trade
17:23:51 - 26-Feb-26
Unknown* 1,415 129.95903 OTC Trade
17:08:04 - 26-Feb-26
Unknown* 1,278 127.84826 SI Trade
Negotiated Trade
17:06:08 - 26-Feb-26
See more Novartis N Ord trades

Novartis N Ord (0QLR) Share Price History

Time period:
to
Date Open High Low Close Volume
26th Feb 2026 (Thu) 129.16 129.33 125.94 127.36 371,678
25th Feb 2026 (Wed) 128.80 128.80 125.58 128.59 950,957
24th Feb 2026 (Tue) 127.69 129.27 124.50 129.27 9,174,223
23rd Feb 2026 (Mon) 126.09 126.27 122.94 126.27 335,527
20th Feb 2026 (Fri) 127.17 127.17 124.00 126.99 1,408,832
19th Feb 2026 (Thu) 128.06 128.06 124.86 127.63 1,322,148
18th Feb 2026 (Wed) 128.59 128.73 125.38 128.73 6,003,584
17th Feb 2026 (Tue) 126.78 128.94 123.62 128.94 906,082
16th Feb 2026 (Mon) 124.84 124.88 121.72 124.88 402,417
13th Feb 2026 (Fri) 124.36 124.36 121.26 124.20 1,084,038
12th Feb 2026 (Thu) 122.85 122.87 119.78 122.87 774,093
11th Feb 2026 (Wed) 121.16 123.15 118.14 123.15 1,291,400
10th Feb 2026 (Tue) 120.36 120.36 117.36 120.06 2,182,797
9th Feb 2026 (Mon) 120.73 120.82 117.72 120.82 770,750
6th Feb 2026 (Fri) 118.93 120.36 115.96 120.36 1,670,903
5th Feb 2026 (Thu) 117.76 119.54 114.82 119.54 806,019
4th Feb 2026 (Wed) 114.81 119.42 111.94 119.42 1,353,348
3rd Feb 2026 (Tue) 117.27 117.45 114.34 117.45 579,820
2nd Feb 2026 (Mon) 114.81 116.73 111.94 116.73 1,605,050
30th Jan 2026 (Fri) 113.98 113.98 111.14 113.98 503,055
29th Jan 2026 (Thu) 112.98 113.14 110.16 113.14 447,333
28th Jan 2026 (Wed) 115.67 115.67 112.78 113.80 877,741
27th Jan 2026 (Tue) 115.44 115.73 112.56 115.73 494,036
26th Jan 2026 (Mon) 115.46 115.58 112.58 115.58 775,913
See more Novartis N Ord price history

Novartis N Ord (0QLR) Share News

TOP NEWS: GlaxoSmithKline Hires Ex-Astra Finance Boss Symonds As Chair

24th Jul 2019 10:34

(Alliance News) - GlaxoSmithKline PLC said Wednesday former AstraZeneca PLC finance chief Jonathan Symonds will replace outgoing Chair Philip Hampton at the FTSE 100-listed drugmaker from the of a Read More

Rio Tinto Appoints Novartis Legal Head As General Counsel Executive

1st Jul 2019 09:13

(Alliance News) - Rio Tinto PLC said Monday it has appointed Barbara Levi as group general counsel with effect from January 1, 2020.She will be replacing Philip Richards, who will retire in Read More

Vectura Gets Milestone Payment On Novartis Submission Of Asthma Drug

24th May 2019 09:35

LONDON (Alliance News) - Pharmaceutical company Vectura Group PLC said it is to receive a USD2.5 million milestone payment from Novartis AG relating to possible new asthma therapy filed a with EU Read More

Oxford BioMedica Notes Kymriah Cancer Treatment's Approval In Japan

26th Mar 2019 12:07

LONDON (Alliance News) - Gene and cell therapy firm Oxford BioMedica PLC on Tuesday noted a drug which uses one of its products has been approved in Japan.Oxford BioMedica is the sole of in Read More

Beximco Pharmaceuticals Acquires 14 New Drug Applications From Sandoz

20th Feb 2019 10:25

LONDON (Alliance News) - Bangladeshi pharmaceutical firm Beximco Pharmaceuticals Ltd said on Wednesday it has agreed to acquire a portfolio of eight Abbreviated New Drug Applications from Sandoz a Read More

See more Novartis N Ord news
FTSE 100 Latest
Value10,846.70
Change40.29

Login to your account

Forgot Password?

Not Registered